The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats

Brain Research
Anna CzarneckaElzbieta Lorenc-Koci

Abstract

Reciprocal interactions between nitrergic and dopaminergic systems play a key role in the control of motor behavior. In the present study, we performed a comparative analysis of motor behavior (locomotor activity, catalepsy, rotational behavior) and monoamine metabolism in the striatum and substantia nigra of unilaterally sham-operated and 6-OHDA-lesioned rats treated with the preferential neuronal nitric oxide synthase (nNOS) inhibitor 7-nitroindazole (7-NI) or the non-selective one N(G)-nitro-L-arginine methyl ester (L-NAME), alone or in combination with L-DOPA. Each NOS inhibitor given alone (50mg/kg) induced a distinct catalepsy 30 min after injection but only 7-NI impaired spontaneous locomotion after 10 min. In 6-OHDA-lesioned rats, chronic L-DOPA (25mg/kg) induced 2.5-h long contralateral rotations. 7-NI (30 and 50mg/kg) markedly reduced the intensity of L-DOPA-induced contralateral rotations while extending their duration until 4.5h whereas L-NAME (50 and 100mg/kg) only tended to attenuate their intensity without affecting the duration. 7-NI but not L-NAME significantly increased endogenous tissue DA levels in the nigrostriatal system of both sham-operated and 6-OHDA-lesioned rats. In L-DOPA-treated group, 7-NI signific...Continue Reading

References

Jan 1, 1990·Blood Vessels·J Reden
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jul 1, 1981·Pharmacology, Biochemistry, and Behavior·R E HeikkilaR C Duvoisin
Nov 21, 1994·Neuroreport·A StrasserM Spatz
Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·R BöckelmannP Riederer
Jan 16, 1995·European Journal of Pharmacology·M S Starr, B S Starr
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·S PrzedborskiT M Dawson
Jan 31, 1996·Neuroreport·M ShibataY Fukuuchi
Dec 29, 1995·Neuroreport·R A MarrasF S Guimarães
May 1, 1996·Clinical Pharmacokinetics·B RosenkranzM J Parnham
Nov 22, 1996·Neuroscience Letters·B E KalischR J Boegman
Aug 26, 1998·Neurology·O Hornykiewicz
Oct 17, 1998·Progress in Neurobiology·W Hauber
Oct 24, 1998·Trends in Pharmacological Sciences·A Reiner, Y Zagvazdin
Dec 5, 1998·Brain Research. Molecular Brain Research·D J EveO J Foster
Mar 16, 2001·Trends in Neurosciences·J P Kiss, E S Vizi
Apr 21, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·T ArakiY Itoyama
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Maria Cavas, José Francisco Navarro
Apr 23, 2002·Psychopharmacology·E A Del BelL P Nucci-da-Silva
Mar 27, 2003·Journal of Neural Transmission·M T SilvaP Jenner
Feb 6, 2004·European Journal of Pharmacology·Elaine A Del BelMarcela Bermúdez-Echeverry
Jun 10, 2004·Neurochemistry International·János P KissE Sylvester Vizi
Aug 13, 2004·The European Journal of Neuroscience·Giuseppe SancesarioGiorgio Bernardi
Aug 27, 2004·Brain : a Journal of Neurology·Raúl de la Fuente-FernándezA Jon Stoessl
Jun 14, 2005·Redox Report : Communications in Free Radical Research·Sarika SinghM Dikshit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.